The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients
Clinical trial NCT06901297 · RECRUITING
Trial details
- NCT number
- NCT06901297
- Sponsor
- Materia Medica Holding
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-03
- Primary completion
- 2027-12-31
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.